Trypanososma brucei rhodesiense Sleeping Sickness, Uganda

Trypanososma brucei rhodesiense Sleeping Sickness, Uganda

Bibliographic Details
Main Authors:	Lea Berrang-Ford, Charles Wamboga, Abbas S.L. Kakembo
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2012-10-01
Series:	Emerging Infectious Diseases
Subjects:	human African trypanosomiasis Trypanosoma brucei rhodesiense parasites sleeping sickness Africa spatial distribution
Online Access:	https://wwwnc.cdc.gov/eid/article/18/10/11-1213_article

Similar Items

New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients
by: Natalia Tiberti, et al.
Published: (2013-12-01)

Reanalyzing the 1900–1920 Sleeping Sickness Epidemic in Uganda
by: E.M. Fèvre, et al.
Published: (2004-04-01)

APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
by: Anneli Cooper, et al.
Published: (2017-05-01)

The double-edged sword of evolution
by: Etty Kruzel-Davila, et al.
Published: (2017-07-01)

Dynamical and optimal control analysis of a seasonal Trypanosoma brucei rhodesiense model
by: Mlyashimbi Helikumi, et al.
Published: (2020-02-01)

Trypanosomiasis in an infant from India
by: Ira Shah, Uma S. Ali, Parmanand Andankar & Rajesh R. Joshi
Published: (2011-06-01)

Reemergence of Human African Trypanosomiasis Caused by Trypanosoma brucei rhodesiense, Ethiopia
by: Adugna Abera, et al.
Published: (2024-01-01)

Mass-treatment and insecticide-spraying of animal reservoirs for emergency control of Rhodesiense sleeping sickness in Uganda
by: J.W. Magona & J. Walubengo
Published: (2011-06-01)

A fractional-order Trypanosoma brucei rhodesiense model with vector saturation and temperature dependent parameters
by: Mlyashimbi Helikumi, et al.
Published: (2020-06-01)

Development of Novel Isoindolone‐Based Compounds against Trypanosoma brucei rhodesiense
by: Dr. Daniel G. Silva, et al.
Published: (2021-09-01)

The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History
by: Harry P. De Koning
Published: (2020-01-01)

Improved Access to Diagnostics for Rhodesian Sleeping Sickness around a Conservation Area in Malawi Results in Earlier Detection of Cases and Reduced Mortality
by: Marshal Lemerani, et al.
Published: (2020-03-01)

Steroid Alkaloids from Holarrhena africana with Strong Activity against Trypanosoma brucei rhodesiense
by: Charles Okeke Nnadi, et al.
Published: (2017-07-01)

Programmed Cell Death in Procyclic Form Trypanosoma brucei rhodesiense - Identification of Differentially Expressed Genes during Con A Induced Death
by: Susan C Welburn, et al.
Published: (1999-03-01)

Relationship between Trypanosoma brucei rhodesiense genetic diversity and clinical spectrum among sleeping sickness patients in Uganda
by: Charles D. Kato, et al.
Published: (2017-10-01)

African Trypanosomiasis: Extracellular Vesicles Shed by <i>Trypanosoma brucei brucei</i> Manipulate Host Mononuclear Cells
by: Tatiana Dias-Guerreiro, et al.
Published: (2021-08-01)

(+)-Spectaline and Iso-6-Spectaline Induce a Possible Cross-Talk between Autophagy and Apoptosis in <em>Trypanosoma brucei rhodesiense</em>
by: Kah Tee Lim, et al.
Published: (2019-07-01)

Molecular Evidence of a Trypanosoma brucei gambiense Sylvatic Cycle in the Human African Trypanosomiasis Foci of Equatorial Guinea
by: Carlos eCordon-Obras, et al.
Published: (2015-07-01)

Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
by: Miebaka Jamabo, et al.
Published: (2023-08-01)

Oxidative Phosphorylation Is Required for Powering Motility and Development of the Sleeping Sickness Parasite Trypanosoma brucei in the Tsetse Fly Vector
by: Caroline E. Dewar, et al.
Published: (2022-02-01)

Cell Cycle Inhibition To Treat Sleeping Sickness
by: Conrad L. Epting, et al.
Published: (2017-11-01)

Trypanosome infections in naturally infected horses and donkeys of three active sleeping sickness foci in the south of Chad
by: Joël Vourchakbé, et al.
Published: (2020-06-01)

<i>Salvia officinalis</i> L.: Antitrypanosomal Activity and Active Constituents against <i>Trypanosoma brucei rhodesiense</i>
by: Núria Llurba Montesino, et al.
Published: (2021-05-01)

Human African Trypanosomiasis in Emigrant Returning to China from Gabon, 2017
by: Xinyu Wang, et al.
Published: (2018-02-01)

An exploratory GIS-based method to identify and characterise landscapes with an elevated epidemiological risk of Rhodesian human African trypanosomiasis
by: Wardrop Nicola A, et al.
Published: (2012-11-01)

Haemoparasitic Infections in Cattle from a <i>Trypanosoma brucei</i> Rhodesiense Sleeping Sickness Endemic District of Eastern Uganda
by: Enock Matovu, et al.
Published: (2020-02-01)

Highly Localized Enrichment of <i>Trypanosoma brucei</i> Parasites Using Dielectrophoresis
by: Devin Keck, et al.
Published: (2020-06-01)

GSK-3 kinase a putative therapeutic target in trypanosomatid parasites
by: Alfredo Prado Diaz, et al.
Published: (2024-03-01)

Potent Antitrypanosomal Activities of 3-Aminosteroids against African Trypanosomes: Investigation of Cellular Effects and of Cross-Resistance with Existing Drugs
by: Charles O. Nnadi, et al.
Published: (2019-01-01)

Chimerization at the AQP2–AQP3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
by: Fabrice E. Graf, et al.
Published: (2015-08-01)

Diversity of trypanosomes in wildlife of the Kafue ecosystem, Zambia
by: David Squarre, et al.
Published: (2020-08-01)

African Trypanosomiasis Gambiense, Italy
by: Zeno Bisoffi, et al.
Published: (2005-11-01)

An essential Trypanosoma brucei protein kinase: a functional analysis of regulation and the identification of inhibitors
by: Marilyn Parsons, et al.
Published: (2023-11-01)

The Production of Trypanosoma Brucei Rhodesiense, Cause of African Sleeping Sickness, and Trypanosoma Cruzi, Cause of American Chagas Disease, on Different Medias and Testing a New Media
by: Ahmet Özbilgin, et al.
Published: (2020-03-01)

Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigs
by: Ilboudo Kadidiata, et al.
Published: (2022-01-01)

Activity of D-carnitine and its derivatives on Trypanosoma infections in rats and mice
by: Manganaro M., et al.
Published: (2003-06-01)

The pathogenicity of blood stream and central nervous system forms of Trypanosoma brucei rhodesiense trypanosomes in laboratory mice: a comparative study [version 2; peer review: 2 approved]
by: Purity Gitonga, et al.
Published: (2023-11-01)

African Trypanosomiasis in Travelers Returning to the United Kingdom
by: David A.J. Moore, et al.
Published: (2002-01-01)

Risk for Human African Trypanosomiasis, Central Africa, 2000–2009
by: Pere P. Simarro, et al.
Published: (2011-12-01)

Estimating the economic and social consequences for patients diagnosed with human African trypanosomiasis in Muchinga, Lusaka and Eastern Provinces of Zambia (2004–2014)
by: Allan Mayaba Mwiinde, et al.
Published: (2017-10-01)